Hikma Pharmaceuticals (HIK) News Today → Gold Mania (From Stansberry Research) (Ad) Free HIK Stock Alerts GBX 1,925 -10.00 (-0.52%) (As of 04:35 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHikma Pharmaceuticals (LON:HIK) Stock Rating Reaffirmed by Berenberg Bankamericanbankingnews.com - April 27 at 1:46 AMEuropean Stocks Close On Strong Note As Investors Cheer Earnings Updatesmarkets.businessinsider.com - April 26 at 9:14 PMHikma Pharmaceuticals' (HIK) Hold Rating Reiterated at Berenberg Bankmarketbeat.com - April 26 at 6:19 AMThe drugs do work as AstraZeneca leads the packthetimes.co.uk - April 25 at 3:57 PMHikma: Pharma giant starts year strong as new product sales surge in key marketsmsn.com - April 25 at 5:33 AMHikma Pharmaceuticals backs outlook after making strong start to 2024lse.co.uk - April 25 at 5:33 AMIs this FTSE growth superstar set to soar even higher on new drug results?msn.com - April 24 at 9:30 AMCarisma Therapeutics (CARM) Price Target Decreased by 10.00% to 9.18msn.com - April 17 at 6:48 PMHKMPY Hikma Pharmaceuticals PLCseekingalpha.com - April 14 at 9:57 AMEuropean Stocks Close Lower Amid Uncertainty About Interest Ratesmarkets.businessinsider.com - April 11 at 3:24 PMI’m considering these 3 undervalued pharma stocks to buy for my portfolio in Apriluk.finance.yahoo.com - April 11 at 5:23 AMBarclays Reiterates "Equal Weight" Rating for Hikma Pharmaceuticals (LON:HIK)marketbeat.com - April 8 at 1:38 PMGeneric Medicine Market To Reach USD 818.3 Billion By 2032, Says DataHorizzon Researchfinance.yahoo.com - April 7 at 8:33 AMFTSE 100 Live: Index slips after topping 8000 and nearing record high, Superdry plungesmsn.com - April 3 at 3:49 PMGlobal Lidocaine Hydrochloride Market Report 2024, by Dosage Form, Application, Distribution Channel and Regionfinance.yahoo.com - March 22 at 5:17 AMLidocaine Hydrochloride Market Forecasted to Reach USD 1.56 Billion by 2034 with Robust Growth in Asia Pacific Regionfinance.yahoo.com - March 21 at 7:16 PMBig pharma shakeup in Morocco as Sanofi sells business to Hikmamsn.com - March 17 at 10:36 AMHyloris Pharmaceuticals SA: Hyloris Reports Full Year Results for 2023 & Provides Business Outlookfinanznachrichten.de - March 15 at 7:18 AMHyloris Reports Full Year Results for 2023 & Provides Business Outlookuk.finance.yahoo.com - March 14 at 4:05 AMFTSE 100 Closes Up 0.12% Ahead of U.K. Jobs Datamorningstar.com - March 13 at 5:19 PMBioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unitmarkets.businessinsider.com - March 13 at 5:19 PMThe 9th edition of the GCC Regulatory Affairs Pharma Summit is set to convene in Dubai in 2024, marking a significant gathering of over 400 professionals, including regional ...msn.com - March 4 at 7:42 AMHyloris Pharmaceuticals SA: Hyloris Announces Launch of Maxigesic IV in the U.S. and approval In Canadafinanznachrichten.de - February 27 at 4:05 PMHyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canadafinance.yahoo.com - February 27 at 4:05 PMHikma Pharmaceuticals (LON:HIK) PT Raised to GBX 2,000 at Berenberg Bankmarketbeat.com - February 27 at 11:26 AMHikma Pharmaceuticals PLC (LON:HIK) Given Average Rating of "Moderate Buy" by Analystsmarketbeat.com - February 27 at 11:25 AMHikma beats profit estimates thanks to narcolepsy drugthetimes.co.uk - February 22 at 2:52 PMFTSE 100 Live 22 February: Lloyds results, shares start higher after Nvidia beats expectationsmsn.com - February 22 at 9:52 AMTOP NEWS: Hikma boosts dividend after year of "significant progress"lse.co.uk - February 22 at 9:52 AMHikma Pharmaceutical FY EPS 85cmarketwatch.com - February 22 at 9:52 AMHikma Pharmaceuticals PLC (LON:HIK) Announces Dividend of $0.47marketbeat.com - February 22 at 9:18 AMHikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facilityfinance.yahoo.com - February 21 at 2:14 PMHikma Pharmaceuticals (LON:HIK) Stock Price Passes Above 200 Day Moving Average of $1,946.54marketbeat.com - February 15 at 3:13 AMHigher-dose naloxone spray didn't save more lives, researchers findmsn.com - February 8 at 7:52 PMHigh-dose opioid reversal spray no better than lower dose in field, US study findsfinance.yahoo.com - February 8 at 2:51 PMNZ-developed intravenous product launches in United Statesmsn.com - February 7 at 12:06 AMMass. AG announces opioid settlements with two companies. State to get $8 million.news.yahoo.com - February 5 at 9:34 AMVirginia expected to receive $2M+ from opioid manufacturer lawsuitmsn.com - February 5 at 12:05 AMAd agency tied to Purdue Pharma settles opioid claims for $350 millionmsn.com - February 2 at 1:20 PMOregon Supreme Court rules lawmakers cannot seek reelection after Senate boycottmsn.com - February 1 at 8:36 PMOpioid settlements announced with two companiesmsn.com - February 1 at 8:36 PMOxyContin marketer, opioid maker announce settlements totaling $500 millionmsn.com - February 1 at 8:36 PMHikma reaches US settlement over opioid epidemicthetimes.co.uk - February 1 at 8:36 PMMassachusetts receives $8 million in opioid settlement, marketing firm ‘helped fuel the nationwide opioid crisis’msn.com - February 1 at 3:34 PMMassachusetts will receive $8 million from marketing company as part of opioid settlementmsn.com - February 1 at 3:34 PMHikma Pharmaceuticals PLC (LON:HIK) Receives Consensus Rating of "Moderate Buy" from Analystsmarketbeat.com - January 20 at 2:26 AMHikma Pharmaceuticals PLC (H5P.DU)ca.finance.yahoo.com - January 18 at 7:37 AMI reckon this FTSE 100 stock, around 35% below its high, is cheap and growing fast!msn.com - January 9 at 1:27 PMThe FTSE 100 Closed Down 0.1% Despite Slight Rise in Oilmorningstar.com - January 9 at 1:27 PMGuardant Health expands into North Africa and the Middle Eastmsn.com - January 8 at 3:04 PM Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HIK and its competitors with MarketBeat's FREE daily newsletter. Email Address Gold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. HIK Media Mentions By Week HIK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIK News Sentiment▼0.630.33▲Average Medical News Sentiment HIK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIK Articles This Week▼52▲HIK Articles Average Week Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HIK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HUTCHMED News Indivior News Dechra Pharmaceuticals News ConvaTec Group News EMIS Group News Genus News Smith & Nephew News Alliance Pharma News Animalcare Group News Allergy Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HIK) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDollar CancelledLear CapitalRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
